Dr. Thomas C. Mayes, Interim Chairman of the Board, Vascular Perfusion Solutions, Inc.
Vascular Perfusion Solutions, Inc. Announces Appointment of Interim Board Chair
August 01, 2024 11:09 ET | Vascular Perfusion Solutions
SAN ANTONIO, TEXAS, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Vascular Perfusion Solutions, Inc. is pleased to announce the appointment of Dr. Thomas C. Mayes as the Interim...
Unravel Biosciences
Vascular Perfusion Solutions and Unravel Biosciences announce partnership to modulate endothelial activation during heart preservation to improve heart transplant outcomes
November 27, 2023 08:47 ET | Vascular Perfusion Solutions
BOSTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Vascular Perfusion Solutions (VPS) and Unravel Biosciences, Inc. (“Unravel”) are partnering to develop a proprietary perfusion solution that will...
Vascular Perfusion S
Vascular Perfusion Solutions Collaborates with Wyss Institute and U.S. Air Force to Study Compound to Improve Organ Transplant Outcomes
April 13, 2022 23:28 ET | Vascular Perfusion Solutions
SAN ANTONIO, April 13, 2022 (GLOBE NEWSWIRE) -- To enhance its research on extending the viability of organs outside the body for the purpose of organ transplant, Vascular Perfusion Solutions (VPS)...